Sabby Management’s Biolase BIOL Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOL
Sabby Management's BIOL Position: Q1 2021 in Review
Sabby Management sold out of Biolase (BIOL) in Q1 2021, closing a stake of 25 shares — an estimated $26K sold.
Sabby Management first reported a position in BIOL in Q1 2015 and held it in 5 quarters. The position peaked at $760K in Q1 2015. 32 funds tracked by Wall St. Rank hold BIOL as of Q1 2021.
- Sabby Management reported no remaining Biolase position as of Q1 2021 after selling out during the quarter.
- Sabby Management sold 25 Biolase shares in Q1 2021, an estimated $26K.
- Sabby Management first reported a position in Biolase in Q1 2015 and held it in 5 quarters.
- Sabby Management's Biolase position peaked at $760K in Q1 2015.
- 32 funds tracked by Wall St. Rank held Biolase as of Q1 2021.
Based on Sabby Management's 13F filing for Q1 2021, filed 17 May 2021.